In Uncanny X-Men #16, written by Gail Simone, the Outliers enter the dark realm of Penumbra and defy the odds against its overlord, Shuvahrak. Impressed, Penumbra's guardian Lady Henrietta Benjmin not ...

Ensuring the safety and quality of pharmaceuticals, such as blood products, vaccines, recombinant proteins, and monoclonal antibodies, is essential. Endotoxins act as a hidden ‘time bomb’ in these ...

Piramal Pharma Solutions is investing $90M to expand two of its U.S. facilities, adding commercial-scale manufacturing ...

Developed markets demonstrate sophisticated freeze drying implementations while addressing workforce optimization through ...

The label-free detection market is experiencing robust expansion, with market valuation expected to grow from USD 2.64 ...

Egham, UK - 6th May 2025 - Essential Pharma ("Essential” or "the Company”), a global pharmaceutical company developing and delivering medicines for patients in niche populations, today announces the ...

Essential is based in Surrey The continuation vehicle was originally led by AlpInvest Gyrus Capital has held a final close on a €700 million single-asset continuation vehicle for Essential Pharma.

Egham, UK – 30 April 2025 – Essential Pharma (“Essential” or“the Company”), a global pharmaceutical company developing and delivering medicines for patients in niche populations, today ...

Lee Morley, Chairman of the Board at Essential Pharma, said: " We are delighted to welcome Jonathan to the Board at Essential Pharma. His deep industry knowledge, strong track record in business ...

Ascendis Pharma will also host a conference call and live webcast on May 1, 2025, at 4:30 p.m. Eastern Time (ET) to discuss its first quarter 2025 financial results.

Essential Pharma operates globally in more than 70 countries, supplying a portfolio of products with a focus on the central nervous system (CNS), gastroenterology, ophthalmology, and rare disease.

Egham, UK – 12 December 2024 – Essential Pharma (“Essential” or“the Company”), an international specialty pharma group focused on ensuring that patients have access to low volume ...